Dong-A ST challenges ‘Viread’ with ‘Virreal,’ hepatitis B treatment

Published: 2017-09-27 16:26:00
Updated: 2017-09-27 16:15:59

Dong-A ST will challenge ‘Viread’ by launching ‘Virreal Tab,’ a hepatitis B treatment, on the 1st of October.

Virreal Tab is a product which changed fumarate from tenofovir disoproxil fumarate, the main substance of ‘Viread Tab, ‘a hepatitis B treatment, to orotates, and acquired approval from t...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.